188 related articles for article (PubMed ID: 16333927)
1. Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia.
Yoon YS; Lee HJ; Yoon HI; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Int J Tuberc Lung Dis; 2005 Nov; 9(11):1215-9. PubMed ID: 16333927
[TBL] [Abstract][Full Text] [Related]
2. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.
Dooley KE; Golub J; Goes FS; Merz WG; Sterling TR
Clin Infect Dis; 2002 Jun; 34(12):1607-12. PubMed ID: 12032896
[TBL] [Abstract][Full Text] [Related]
3. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis.
Long R; Chong H; Hoeppner V; Shanmuganathan H; Kowalewska-Grochowska K; Shandro C; Manfreda J; Senthilselvan A; Elzainy A; Marrie T
Clin Infect Dis; 2009 May; 48(10):1354-60. PubMed ID: 19348594
[TBL] [Abstract][Full Text] [Related]
4. The WHO/IUATLD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfalls.
Sterling TR
Int J Tuberc Lung Dis; 2004 Dec; 8(12):1396-400. PubMed ID: 15636484
[TBL] [Abstract][Full Text] [Related]
5. Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis.
Golub JE; Bur S; Cronin WA; Gange S; Sterling TR; Oden B; Baruch N; Comstock GW; Chaisson RE
Int J Tuberc Lung Dis; 2005 Apr; 9(4):392-7. PubMed ID: 15832463
[TBL] [Abstract][Full Text] [Related]
6. Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease.
Gaba PD; Haley C; Griffin MR; Mitchel E; Warkentin J; Holt E; Baggett P; Sterling TR
Arch Intern Med; 2007 Nov; 167(21):2317-22. PubMed ID: 18039990
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis.
Ginsburg AS; Hooper N; Parrish N; Dooley KE; Dorman SE; Booth J; Diener-West M; Merz WG; Bishai WR; Sterling TR
Clin Infect Dis; 2003 Dec; 37(11):1448-52. PubMed ID: 14614666
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone resistance in renal isolates of Mycobacterium tuberculosis.
Webster D; Long R; Shandro C; Pettipas J; Leblanc J; Davidson R; Fanning A
Int J Tuberc Lung Dis; 2010 Feb; 14(2):217-22. PubMed ID: 20074414
[TBL] [Abstract][Full Text] [Related]
9. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary tuberculosis presenting as community-acquired pneumonia.
Asnis DS; Cherian S; Sun T; Shrestha S; Santucci T
Clin Infect Dis; 2002 Dec; 35(12):1574-5. PubMed ID: 12471584
[No Abstract] [Full Text] [Related]
11. Fluoroquinolones may delay the diagnosis of tuberculosis.
Ang D; Hsu AA; Tan BH
Singapore Med J; 2006 Sep; 47(9):747-51. PubMed ID: 16924354
[TBL] [Abstract][Full Text] [Related]
12. Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome.
Nguyen LH; Hsu DI; Ganapathy V; Shriner K; Wong-Beringer A
J Antimicrob Chemother; 2008 Mar; 61(3):714-20. PubMed ID: 18222951
[TBL] [Abstract][Full Text] [Related]
13. Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic?
Wang M; Fitzgerald JM; Richardson K; Marra CA; Cook VJ; Hajek J; Elwood RK; Bowie WR; Marra F
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1062-8. PubMed ID: 21740669
[TBL] [Abstract][Full Text] [Related]
14. [Differential diagnosis of pulmonary tuberculosis and community-acquired pneumonia].
Deĭkina ON; Mishin VIu; Demikhova OV
Probl Tuberk Bolezn Legk; 2007; (1):39-42. PubMed ID: 17338353
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study.
Wang JY; Lee CH; Yu MC; Lee MC; Lee LN; Wang JT
Eur Respir J; 2015 Aug; 46(2):567-70. PubMed ID: 25900374
[No Abstract] [Full Text] [Related]
16. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
[TBL] [Abstract][Full Text] [Related]
17. Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis?
Abiad H
Clin Infect Dis; 2002 Dec; 35(12):1572; author reply 1572-3. PubMed ID: 12471582
[No Abstract] [Full Text] [Related]
18. Fluoroquinolones in community-acquired pneumonia when tuberculosis is around: an instructive case.
Grupper M; Potasman I
Am J Med Sci; 2008 Feb; 335(2):141-4. PubMed ID: 18277123
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects of gemifloxacin on the delay of tuberculosis treatment.
Kim SY; Yim JJ; Park JS; Park SS; Heo EY; Lee CH; Chung HS; Kim DK
J Korean Med Sci; 2013 Mar; 28(3):378-82. PubMed ID: 23486643
[TBL] [Abstract][Full Text] [Related]
20. Outpatient treatment of community-acquired pneumonia: evolving trends and a focus on fluoroquinolones.
Carrie AG; Kozyrskyj AL
Can J Clin Pharmacol; 2006; 13(1):e102-11. PubMed ID: 16585811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
